Name: Plasmalogens: Key Components in Alzheimer's & Cardiovascular Disorders | DrTalks
Uploaded: 2021-10-20T07:14:12-07:00
Description: What Are Plasmalogens? Critical Cell Membrane Components In Alzheimers And Cardiovascular Disorders

Alzheimers

Genetics

Plasmalogens: Key Components in Alzheimer’s & Cardiovascular Disorders

Telomere Summit- January 2022

<h6>Joseph M. Raffaele, M.D.</h6>
Hello, this is Dr. Joseph Raffaele, your host for the Telomere Summit. Today, I&#8217;m very pleased to have on the show, Dr. Dayan Goodenowe. Who will talk about his research into plasmalogens and the relationship to many diseases, including Alzheimer&#8217;s disease. Dr. Goodenowe&#8217;s research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life is as insatiable today as it was 30 years ago. In those 30 years, Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies designed and manufactured novel and natural biochemical precursors and identified biochemical prodromes of numerous diseases, including Alzheimer&#8217;s disease and dementia, Parkinson&#8217;s disease, multiple sclerosis, stroke, autism, ALS , schizophrenia, bipolar disorder, depression and cancers of the colon, pancreas, ovaries, breasts, and many others. 
He is just getting warmed up. Dr. Goodenowe is now going beyond disease and the detection of biochemical dysfunctions to diagnose and the correction of biochemical dysfunction to treat disease. Dr. Goodenowe&#8217;s new focus is to defeat the entropy of aging by creating strategic biochemical and bio functional reserve capacity in advance of known disease risks, such that the human body can maintain the physical and biological functions of life indefinitely and without disease. Welcome Dayan. I am so glad to have you on here. I know we have lots of conversations about patients that have done your lab testing, but I don&#8217;t know that we&#8217;ve actually ever really talked about the journey that you took to get to this fascinating area of plasmalogen medicine and cell membrane medicine. I&#8217;m sure that I would love to, and our listeners would probably love to hear about how you got here

https://drsummits.s3.us-west-1.amazonaws.com/2022+Summits/Telomere+Summit/Transcripts/Dayan+Goodenowe+PhD+Telomere+Transcript+File.pdf

Dr. Goodenowe’s research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life is as insatiable today as it was 30 years ago. In those 30 years, Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel and natural biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and cancers of the colon, pancreas, ovary, breast, lung, kidney, liver, stomach, and others.

Dayan Goodenowe, PhD

Dr. Raffaele received his B.A. in philosophy from Princeton University and his M.D. from Drexel University Medical School in 1989. He trained at The New York Hospital/Cornell University Medical Center and was formerly a clinical assistant professor of medicine at Dartmouth Medical School. Dr. Raffaele is board certified in internal medicine, a member of the Endocrine Society, and a diplomat of the American Board of Anti-Aging Medicine. In 1997, he co-founded PhysioAge Medical Group, where he exclusively practiced age-management medicine, focusing on personalized hormone optimization and physiological age assessment.

Plasmalogens: Key Components in Alzheimer’s & Cardiovascular Disorders

Joseph Raffaele, MD

Dayan Goodenowe, PhD

Summary

Content Provided By

Joseph Raffaele, MD

Guest Experts

Dayan Goodenowe, PhD